Notice of Establishment, 14035 [2011-6023]
Download as PDF
<![CDATA[
14035
Federal Register / Vol. 76, No. 50 / Tuesday, March 15, 2011 / Notices
Type of Information Collection Request:
Existing Collection in Use Without an
OMB Number. Need and Use of
Information Collection: The purpose of
the online application form and the
Web-based update mailer is to collect
information about genetics professionals
to be included in the NCI Cancer
Genetics Services Directory on NCI’s
Cancer.gov Web site. The information
collected includes name, practice
locations, professional qualifications,
and areas of specialization. Frequency of
Response: Information is collected once
via the online application form, and
then updated annually via the Webbased mailer. Affected Public:
Individuals. Type of Respondents:
Genetics professionals including nurses,
physicians, genetic counselors, and
other professionals who provide
services related to cancer genetics. The
annual reporting burden is estimated at
180 hours (see Table below). There are
no Capital Costs, Operating Costs, and/
or Maintenance Costs to report.
TABLE 1—ESTIMATES OF ANNUAL BURDEN HOURS
Number of
respondents
Tool
Genetics Professionals ...........................
Application Form .........................
60
1
Web-based Update Mailer ..........
600
.....................................................
660
Totals ...............................................
srobinson on DSKHWCL6B1PROD with NOTICES
Average time
per response
minutes/hour
(hours)
Frequency of
response
Type of respondents
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies should
address one or more of the following
points: (1) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) Evaluate the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and (4) Minimize the burden
of the collection of information on those
who are to respond, including the use
of appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
For Further Information Contact: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact Margaret Beckwith,
Acting Branch Chief, International
Cancer Research Databank Branch,
Office of Cancer Content Management,
Office of Communication and
Education, National Cancer Institute,
6116 Executive Blvd., Rockville, MD
20852, or call non-toll-free number 301–
496–9096 or e-mail your request,
including your address to:
mbeckwit@mail.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
VerDate Mar<15>2010
16:50 Mar 14, 2011
Jkt 223001
Annual burden
hours
1
30/60
(.50)
15/60
(0.25)
150
........................
........................
180
Dated: March 9, 2011.
Vivian Horovitch-Kelley,
NCI Project Clearance Liaison, National
Institutes of Health.
Dated: March 9, 2011.
Francis S. Collins,
Director, National Institutes of Health.
[FR Doc. 2011–6021 Filed 3–14–11; 8:45 am]
30
BILLING CODE 4140–01–P
[FR Doc. 2011–6023 Filed 3–14–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Pursuant to the Federal Advisory
Committee Act, as amended (5 U.S.C.
app.), the Director, National Institutes of
Health (NIH), announces the
establishment of the NCI-Frederick
Advisory Committee.
The Council will provide advice and
recommendations to the Director,
National Cancer Institute (NCI), and the
Associate Director, NCI-Frederick, on
the optimal use of the NCI-Frederick
facility to rapidly meet the most urgent
needs of the NCI. The Committee will
consist of 16 members, including the
Chair, appointed by the Director, NCI.
Members will be authorities
knowledgeable in drug and vaccine
development, clinical trials support,
AIDS research, bioinformatics,
genomics, nanotechnology, biological
repositories, and basic research in
immunology and infectious diseases.
Duration of this committee is
continuing unless formally determined
by the Director, NCI that termination
would be in the best interest of the
public.
Frm 00068
Fmt 4703
Sfmt 4703
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meetings
Notice of Establishment
PO 00000
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel; Career
Development, Research Training and
Pathways to Independence Grant Review.
Date: March 29, 2011.
Time: 10 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
E:\FR\FM\15MRN1.SGM
15MRN1
]]>Agencies
[Federal Register Volume 76, Number 50 (Tuesday, March 15, 2011)]
[Notices]
[Page 14035]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-6023]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Establishment
Pursuant to the Federal Advisory Committee Act, as amended (5
U.S.C. app.), the Director, National Institutes of Health (NIH),
announces the establishment of the NCI-Frederick Advisory Committee.
The Council will provide advice and recommendations to the
Director, National Cancer Institute (NCI), and the Associate Director,
NCI-Frederick, on the optimal use of the NCI-Frederick facility to
rapidly meet the most urgent needs of the NCI. The Committee will
consist of 16 members, including the Chair, appointed by the Director,
NCI. Members will be authorities knowledgeable in drug and vaccine
development, clinical trials support, AIDS research, bioinformatics,
genomics, nanotechnology, biological repositories, and basic research
in immunology and infectious diseases.
Duration of this committee is continuing unless formally determined
by the Director, NCI that termination would be in the best interest of
the public.
Dated: March 9, 2011.
Francis S. Collins,
Director, National Institutes of Health.
[FR Doc. 2011-6023 Filed 3-14-11; 8:45 am]
BILLING CODE 4140-01-P
